Holen Sie sich die Stockscreener-App
78.98
0.18%
0.11
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ALC?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$78.87
Offen:
$79.73
24-Stunden-Volumen:
949.62K
Relative Volume:
0.45
Marktkapitalisierung:
$38.79B
Einnahmen:
$10.19B
Nettoeinkommen (Verlust:
$1.05B
KGV:
37.53
EPS:
2.1044
Netto-Cashflow:
$1.38B
1W Leistung:
-0.24%
1M Leistung:
+6.81%
6M Leistung:
-9.68%
1J Leistung:
-8.63%
1-Tages-Spanne:
$78.98
$80.15
1-Wochen-Bereich:
$78.76
$81.69
52-Wochen-Spanne:
$71.55
$99.20
Alcon Inc Stock (ALC) Company Profile
Vergleichen Sie ALC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
78.98 | 38.74B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
ISRG
Intuitive Surgical Inc
|
560.65 | 200.96B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
189.05 | 54.09B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
RMD
Resmed Inc
|
247.44 | 36.50B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
267.39 | 19.36B | 2.96B | 487.70M | 344.00M | 6.6758 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-05-20 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-05-14 | Bestätigt | BTIG Research | Buy |
| 2025-03-28 | Bestätigt | Needham | Buy |
| 2025-03-25 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-01-24 | Bestätigt | Needham | Buy |
| 2025-01-10 | Hochstufung | Redburn Atlantic | Neutral → Buy |
| 2024-12-17 | Bestätigt | Needham | Buy |
| 2024-11-12 | Bestätigt | Needham | Buy |
| 2024-10-10 | Hochstufung | Redburn Atlantic | Sell → Neutral |
| 2024-09-10 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-07-15 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2024-05-15 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2024-04-10 | Eingeleitet | Goldman | Buy |
| 2024-03-14 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2024-01-23 | Eingeleitet | Bernstein | Outperform |
| 2023-12-18 | Herabstufung | Redburn Atlantic | Neutral → Sell |
| 2023-12-12 | Eingeleitet | Stifel | Buy |
| 2023-12-04 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-08-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-05-10 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2023-03-01 | Hochstufung | Societe Generale | Sell → Hold |
| 2022-12-22 | Eingeleitet | Mizuho | Buy |
| 2022-11-17 | Herabstufung | Societe Generale | Hold → Sell |
| 2022-08-11 | Herabstufung | Societe Generale | Buy → Hold |
| 2022-05-13 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-05-12 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2022-04-08 | Eingeleitet | Needham | Buy |
| 2022-03-11 | Eingeleitet | BofA Securities | Buy |
| 2022-01-18 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-01 | Eingeleitet | Oppenheimer | Perform |
| 2021-07-14 | Eingeleitet | Deutsche Bank | Buy |
| 2021-05-06 | Hochstufung | Citigroup | Sell → Neutral |
| 2021-03-22 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-11-12 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-07-06 | Herabstufung | Citigroup | Neutral → Sell |
| 2020-07-06 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-06-16 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-04-08 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | Hochstufung | Argus | Hold → Buy |
| 2020-03-24 | Hochstufung | Societe Generale | Sell → Hold |
| 2020-03-13 | Hochstufung | UBS | Neutral → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Neutral |
| 2020-02-26 | Hochstufung | Berenberg | Hold → Buy |
| 2020-01-08 | Eingeleitet | Argus | Hold |
| 2019-10-29 | Eingeleitet | Stephens | Equal-Weight |
| 2019-08-21 | Bestätigt | BofA/Merrill | Neutral |
| 2019-06-24 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2019-06-14 | Eingeleitet | BTIG Research | Neutral |
| 2019-05-10 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-05-02 | Eingeleitet | Credit Suisse | Outperform |
Alle ansehen
Alcon Inc Aktie (ALC) Neueste Nachrichten
STAAR Surgical stock jumps 10% after Alcon sweetens buyout offer — investor says deal is 'worth substantially more' - MSN
STAAR Surgical (STAA) Shares Skyrocket, What You Need To Know - TradingView
Broadwood Partners Challenges Alcon's (ALC) Acquisition of Staar Surgical - GuruFocus
Alcon bumps STAAR Surgical bid to $30.75, but Broadwood remains vehemently against - Investing.com Canada
Broadwood Partners Still Opposes Alcon's Higher Bid for Staar Surgical - marketscreener.com
Broadwood Partners Responds to Alcon?s Increase to Acquisition Price of STAAR Surgical - marketscreener.com
STAAR Surgical Stock Jumps 10% After Alcon Sweetens Buyout Offer — Investor Says Deal Is ‘Worth Substantially More’ - Stocktwits
Broadwood continues to oppose STAAR sale to Alcon despite price bump By Investing.com - Investing.com Canada
Alcon (NYSE: ALC) Faces Broadwood Pushback on Raised $30.75 STAAR Deal Offer - Stock Titan
Alcon Increases Offer to Acquire Staar to $1.6B - Orange County Business Journal
Swiss Stocks Slip As Alcon Ups Its Staar Surgical Bid - Finimize
STAAR Surgical Company Enters into Amendment to the Agreement and Plan of Merger with Alcon - marketscreener.com
Staar Surgical Shares Surge as Alcon Boosts its Buyout Price - marketscreener.com
Alcon Ups Takeover Bid for Staar Surgical Under Amended Merger Deal - marketscreener.com
Alcon, STAAR Amend Merger Agreement as Deal Looks Set to Move Forward - Medical Product Outsourcing
Alcon (ALC) Enhances Offer for Staar Surgical Acquisition - GuruFocus
Alcon lifts bid for medical technology firm Staar to $1.6 billion - marketscreener.com
STAAR Surgical jumps after Alcon raises offer to $30.75/share in cash - MSN
Staar Surgical raises merger offer price in amended agreement with Alcon - Investing.com India
Alcon raises offer to $30.75 per share in amended STAAR acquisition deal - Investing.com Australia
Alcon Increases Bid to Acquire STAAR Surgical to $1.6 Billion - marketscreener.com
STAAR Surgical stock soars after Alcon raises acquisition offer By Investing.com - Investing.com UK
Alcon announces amended merger agreement with Staar Surgical - marketscreener.com
Alcon Announces Amended Merger Agreement with STAAR Surgical - Business Wire
Alcon Q3 2025 presentation slides: 6% sales growth amid margin pressure - Investing.com Canada
Why STAAR Surgical (STAA) Shares Are Plunging Today - TradingView
STAAR Surgical’s Sale To Alcon Faces Doubts And Pushback - Finimize
STAAR Surgical Shareholder Broadwood Partners Reiterates Opposition to Alcon Transaction - marketscreener.com
Broadwood urges STAAR shareholders to reject Alcon deal despite go-shop By Investing.com - Investing.com South Africa
Broadwood urges STAAR shareholders to reject Alcon deal despite go-shop - Investing.com Canada
Broadwood Partners Reiterates Opposition to STAAR Surgical’s Sale to Alcon Following Conclusion of Performative Go-Shop Process - Markets Financial Content
STAAR Surgical Says Go-Shop Period in Alcon Deal Expires With No Competing Proposals - marketscreener.com
Alcon (ALC) Nears Completion of Staar Surgical Merger - GuruFocus
Staar Surgical Concludes Go-Shop Period with Alcon - TipRanks
Broadwood Partners: Proxy Advisory Firm Egan-Jones Reaffirms Its Recommendation STAAR Surgical Shareholders Vote “AGAINST” Sale to Alcon - marketscreener.com
Broadwood Partners: Proxy Advisory Firm Egan-Jones Reaffirms Its Recommendation STAAR Surgical Shareholders Vote "AGAINST" Sale to Alcon - Yahoo Finance
Ophthalmic Drugs Market Size to Cross USD 62.74 Billion by 2032, Driven by Advances in Eye Care Treatments and Rising Global Vision Disorders - GlobeNewswire Inc.
Reassessing Alcon (SWX:ALC): Is the Recent Share Price Rebound Leaving the Stock Undervalued? - Yahoo Finance
Why analysts maintain buy rating on Alcon Inc. (2U3) stock2025 Retail Activity & Verified Entry Point Signals - Newser
Dry Eye Disease Treatment Market Outlook Report 2032 | Alcon - openPR.com
Is Alcon Inc. Ordinary Shares stock positioned for digital growth eraQuarterly Portfolio Report & Consistent Growth Equity Picks - Newser
Will Alcon Inc. Ordinary Shares stock benefit from infrastructure billGDP Growth & Weekly Market Pulse Alerts - Newser
Healthcare Investor Exits $13 Million Stake STAAR Surgical Stake as Alcon Deal Drama Looms - Yahoo Finance
Broadwood reiterates push for STAAR Surgical board shake-up as Alcon vote nears - Investing.com Canada
SOBE ordered to pay more than $424,000 to piping company in lawsuit - WFMJ.com
Can Alcon Inc. (2U3) stock surprise with quarterly resultsJuly 2025 Selloffs & Weekly Watchlist for Consistent Profits - Newser
Will Alcon Inc. Ordinary Shares stock benefit from sector leadershipTrade Volume Summary & Daily Stock Trend Watchlist - Newser
RBC Capital Reaffirms Their Buy Rating on Alcon (ALC) - The Globe and Mail
Why pension funds invest in Alcon Inc. Ordinary Shares stock - Newser
Alcon upgraded at BofA Securities to Buy on earnings growth potential - MSN
What is the fair value of Alcon Inc. stock nowBull Run & Stepwise Swing Trade Plans - Newser
Finanzdaten der Alcon Inc-Aktie (ALC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.90%
0.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):